Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Valaciclovir has comparable efficacy and safety to aciclovir in recurrent genital herpes

June 16, 1997

Pharmacokinetics of DW-116, ciprofloxacin and rufloxacin compared in animals

June 16, 1997

In vitro profile of new quinolone: HSR-903

June 16, 1997

AM-1155: in vitro and in vivo antichlamydial activity

June 13, 1997

Bay-12-8039: time-kill and PAE studies

June 13, 1997

Activity of Sch-48973 against enteroviruses

June 13, 1997

D-0870 for AIDS-related oral candidiasis

June 13, 1997

Alfa Wassermann and Merckle sign development and marketing agreement for rifaximin

June 12, 1997

Successful phase III trials of Cytolex trigger milestone payment for Magainin

June 11, 1997

Peptidomimetic inhibitors of fungal NMT prepared by Searle

June 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...